ŞEHİR e-arşiv

Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer

Files in this item

This item appears in the following Collection(s)

Search ŞEHİR e-arşiv


Advanced Search

Browse

My Account

Statistics